These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

471 related articles for article (PubMed ID: 33868269)

  • 1. Role of Epigenetic Regulation in Plasticity of Tumor Immune Microenvironment.
    Yang Y; Wang Y
    Front Immunol; 2021; 12():640369. PubMed ID: 33868269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenetic interplay between immune, stromal and cancer cells in the tumor microenvironment.
    Garcia-Gomez A; Rodríguez-Ubreva J; Ballestar E
    Clin Immunol; 2018 Nov; 196():64-71. PubMed ID: 29501540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetics and immunotherapy: The current state of play.
    Dunn J; Rao S
    Mol Immunol; 2017 Jul; 87():227-239. PubMed ID: 28511092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Fate of Th17 Cells is Shaped by Epigenetic Modifications and Remodeled by the Tumor Microenvironment.
    Renaude E; Kroemer M; Loyon R; Binda D; Borg C; Guittaut M; Hervouet E; Peixoto P
    Int J Mol Sci; 2020 Feb; 21(5):. PubMed ID: 32121394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer Epigenetics, Tumor Immunity, and Immunotherapy.
    Cao J; Yan Q
    Trends Cancer; 2020 Jul; 6(7):580-592. PubMed ID: 32610068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anticancer potential of naturally occurring immunoepigenetic modulators: A promising avenue?
    Schnekenburger M; Dicato M; Diederich MF
    Cancer; 2019 May; 125(10):1612-1628. PubMed ID: 30840315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Understanding the epigenetic regulation of tumours and their microenvironments: opportunities and problems for epigenetic therapy.
    Liu M; Zhou J; Chen Z; Cheng AS
    J Pathol; 2017 Jan; 241(1):10-24. PubMed ID: 27770445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunosuppressive Roles of Galectin-1 in the Tumor Microenvironment.
    Huang Y; Wang HC; Zhao J; Wu MH; Shih TC
    Biomolecules; 2021 Sep; 11(10):. PubMed ID: 34680031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenetic Modifiers: Anti-Neoplastic Drugs With Immunomodulating Potential.
    Maes K; Mondino A; Lasarte JJ; Agirre X; Vanderkerken K; Prosper F; Breckpot K
    Front Immunol; 2021; 12():652160. PubMed ID: 33859645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of Epigenetic Modifications in Inhibitory Immune Checkpoints in Cancer Development and Progression.
    Saleh R; Toor SM; Sasidharan Nair V; Elkord E
    Front Immunol; 2020; 11():1469. PubMed ID: 32760400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic Cancer Vaccines-T Cell Responses and Epigenetic Modulation.
    Kartikasari AER; Prakash MD; Cox M; Wilson K; Boer JC; Cauchi JA; Plebanski M
    Front Immunol; 2018; 9():3109. PubMed ID: 30740111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigenetic Modifications in Tumor-Associated Macrophages: A New Perspective for an Old Foe.
    Niu Y; Chen J; Qiao Y
    Front Immunol; 2022; 13():836223. PubMed ID: 35140725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolites in the Tumor Microenvironment Reprogram Functions of Immune Effector Cells Through Epigenetic Modifications.
    Li Y; Wu Y; Hu Y
    Front Immunol; 2021; 12():641883. PubMed ID: 33927716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigenetic regulation in the tumor microenvironment: molecular mechanisms and therapeutic targets.
    Yang J; Xu J; Wang W; Zhang B; Yu X; Shi S
    Signal Transduct Target Ther; 2023 May; 8(1):210. PubMed ID: 37217462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunosuppressive cells in tumor immune escape and metastasis.
    Liu Y; Cao X
    J Mol Med (Berl); 2016 May; 94(5):509-22. PubMed ID: 26689709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methylation of immune synapse genes modulates tumor immunogenicity.
    Berglund A; Mills M; Putney RM; Hamaidi I; Mulé J; Kim S
    J Clin Invest; 2020 Feb; 130(2):974-980. PubMed ID: 31714899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetic regulation of immune checkpoints: another target for cancer immunotherapy?
    Ali MA; Matboli M; Tarek M; Reda M; Kamal KM; Nouh M; Ashry AM; El-Bab AF; Mesalam HA; Shafei AE; Abdel-Rahman O
    Immunotherapy; 2017 Jan; 9(1):99-108. PubMed ID: 28000527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigenetic Regulations in Autoimmunity and Cancer: from Basic Science to Translational Medicine.
    Hui L; Ziyue Z; Chao L; Bin Y; Aoyu L; Haijing W
    Eur J Immunol; 2023 Apr; 53(4):e2048980. PubMed ID: 36647268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor-intrinsic signaling pathways: key roles in the regulation of the immunosuppressive tumor microenvironment.
    Yang L; Li A; Lei Q; Zhang Y
    J Hematol Oncol; 2019 Nov; 12(1):125. PubMed ID: 31775797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigenetic regulation of tumor-immune symbiosis in glioma.
    Liu Y; Ali H; Khan F; Pang L; Chen P
    Trends Mol Med; 2024 May; 30(5):429-442. PubMed ID: 38453529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.